Akari Therapeutics Plc - AKTX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$311K
QoQ value delta ($000)
-$966K
(-75.65%)
Implied price effect (QoQ)
+1139.42%
Shares
Total shares
87,496
QoQ shares delta
-4,365,360
(-98.04%)
Total shares held by funds (by quarter)
Market chart (AKTX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 6 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 200 | 38,922 | 0.0% |
| Cresset Asset Management, LLC | 105 | 20,561 | 0.0% |
| Skyview Financial Group LLC | 5 | 20,575 | 0.01% |
| IFP Advisors, Inc | 1 | 7,431 | 0.0% |
| MORGAN STANLEY | 0 | 1 | 0.0% |
| Truvestments Capital LLC | 0 | 1 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 5 | 0.0% |